789
CALY-002, AN ANTI-IL-15 ANTIBODY, PREVENTS GLUTEN CHALLENGE-INDUCED MUCOSAL DAMAGE AND INFLAMMATION: RESULTS FROM A PHASE 1A/B STUDY
Date
May 20, 2024
Tracks
Related Products
INTERIM RESULTS FROM A FIRST-IN-HUMAN STUDY OF THE ANTI-IL-15 ANTIBODY CALY-002 FOR TREATING CELIAC DISEASE AND EOSINOPHILIC ESOPHAGITIS
INTRODUCTION Interleukin-15 (IL-15) is an important cytokine involved in tissue homeostasis and inflammation, and a potent regulator of innate and adaptive immune responses…
NAVIGATING THE MAZE OF FUNCTIONAL DYSPEPSIA: EMERGENCE OF A NEW ENTITY, POSTPRANDIAL EPIGASTRIC PAIN
BACKGROUND: Historically, functional dyspepsia (FD) has been subdivided into postprandial distress syndrome, PDS, with meal-related symptoms (i.e. early satiation or postprandial fullness) and epigastric pain syndrome, EPS, defined as meal-unrelated (i.e…
ACUTE MUCOSAL REACTIONS FOLLOWING FOOD ADMINISTRATION IN IRRITABLE BOWEL SYNDROME ARE NOT ASSOCIATED WITH ALTERED PERMEABILITY OR MAST CELL ACTIVATION EX VIVO
INTRODUCTION: Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction characterized by abdominal pain associated with bowel movements. Local allergic reactions have been implicated as a mechanism underlying the food-related symptoms often reported by IBS patients…
DUODENAL T CELL PROFILE PREDICTS RESPONSE TO HIGH-DOSE PROTON PUMP INHIBITORS IN FUNCTIONAL DYSPEPSIA
I: Functional dyspepsia (FD) is a chronic gastrointestinal (GI) disorder with incompletely understood pathophysiology…